enGene Holdings Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that enGene Holdings Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q1 | 2026 | Jan 31, 2026 | ($29.75M) | Mar 9, 2026 |
| Q3 | 2025 | Jul 31, 2025 | ($28.99M) | Sep 11, 2025 |
| Q3 | 2025 | Apr 30, 2025 | ($25.82M) | Sep 11, 2025 |
| Q2 | 2025 | Apr 30, 2025 | ($25.82M) | Jun 12, 2025 |
| Q3 | 2025 | Jan 31, 2025 | ($24.62M) | Sep 11, 2025 |
| Q1 | 2026 | Jan 31, 2025 | ($24.62M) | Mar 9, 2026 |
| Q2 | 2025 | Jan 31, 2025 | ($24.62M) | Jun 12, 2025 |
| Q3 | 2025 | Jul 31, 2024 | ($14.15M) | Sep 11, 2025 |
| Q2 | 2025 | Apr 30, 2024 | ($14.98M) | Jun 12, 2025 |
| Q3 | 2025 | Apr 30, 2024 | ($14.98M) | Sep 11, 2025 |
| Q3 | 2025 | Jan 31, 2024 | ($10.71M) | Sep 11, 2025 |
| Q1 | 2025 | Jan 31, 2024 | ($10.71M) | Mar 10, 2025 |
| Q2 | 2025 | Jan 31, 2024 | ($10.71M) | Jun 12, 2025 |
| Q3 | 2024 | Jul 31, 2023 | ($4.72M) | Sep 10, 2024 |
| Q2 | 2024 | Apr 30, 2023 | ($5.28M) | Jun 14, 2024 |
| Q3 | 2024 | Apr 30, 2023 | ($5.28M) | Sep 10, 2024 |
| Q2 | 2024 | Jan 31, 2023 | ($7.42M) | Jun 14, 2024 |
| Q1 | 2024 | Jan 31, 2023 | ($7.42M) | Mar 11, 2024 |
| Q3 | 2024 | Jan 31, 2023 | ($7.42M) | Sep 10, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q1 | 2026 | Jan 31, 2026 | ($31.19M) | Mar 9, 2026 |
| Q3 | 2025 | Jul 31, 2025 | ($29.95M) | Sep 11, 2025 |
| Q2 | 2025 | Apr 30, 2025 | ($27.12M) | Jun 12, 2025 |
| Q1 | 2026 | Jan 31, 2025 | ($26.61M) | Mar 9, 2026 |
| Q3 | 2025 | Jul 31, 2024 | ($16.76M) | Sep 11, 2025 |
| Q2 | 2025 | Apr 30, 2024 | ($17.31M) | Jun 12, 2025 |
| Q1 | 2025 | Jan 31, 2024 | ($10.77M) | Mar 10, 2025 |
| Q3 | 2024 | Jul 31, 2023 | ($6.25M) | Sep 10, 2024 |
| Q2 | 2024 | Apr 30, 2023 | ($4.74M) | Jun 14, 2024 |
| Q1 | 2024 | Jan 31, 2023 | ($4.63M) | Mar 11, 2024 |